Elanco Animal Health Incorporated announced today a series of 2030 sustainability commitments, supporting the UN Sustainable Development Goals (SDGs), addressing societal challenges and underscoring the company’s role in improving the health of animals, which also improves the health of people and the planet. The new goals represent the first sustainability targets set by Elanco since the company was spun out of pharmaceutical giant Eli Lilly in 2018.

The company’s new sustainability initiatives include the introduction of three 2030 goals, or “Healthy Purpose Pledges,” including:

  • Protein Pledge: Create more resilient food systems by enabling 57 million more people to access their annual nutritious protein needs.
  • Planet Pledge: Remove 21 million tons of emissions from customers’ farms while reducing the company’s own impact on the planet.
  • Pet Pledge: Improve the world’s wellbeing by helping at least 100 million healthy pets help people.

In the pursuit of these new commitments, the company provided details regarding the approach to each pledge. The Elanco Protein Pledge aims to improve the efficiency and sustainability of every farmer the company works with, improve the health and welfare of 3 billion farm animals and support and enhance agricultural productivity and income of 250,000 dairy and poultry smallholder farmers; Under the Elanco’s Planet Pledge, the company aims to be customers’ lead partner on the journey toward net zero emissions on their farms, grow the product portfolio with environmental benefits and accelerate toward sustainable packaging while achieving 100% renewable sources of electricity across the company’s operations, and; the  Elanco’s Pet Pledge will see the company working with veterinarians and pet owners, delivering a constant flow of new medicines and health products for pets, and helping the world understand and experience the benefits of pets on wellbeing.

Jeff Simmons, president and CEO at Elanco, said:

“Business can be a unique force for good, and at Elanco, we believe we have the opportunity and responsibility to help tackle key societal challenges. Elanco’s Healthy Purpose sustainability commitments, the first of its kind in the animal health industry, advances the world’s wellbeing while supporting and strengthening our own business. It all starts with a healthy, strong enterprise driven by the growth, innovation and margin expansion agenda we are executing against. Through these efforts, Elanco is focused on creating value for our customers, employees, shareholders and society as a whole.”

Simmons added:

“Three clear reasons will help us achieve our Healthy Purpose Pledges – the Elanco Differentiators: People, Access, and Innovation. With the industry’s most passionate, highly-engaged people, innovation created with purpose, and access to 19 species of animals in nearly 100 countries, Elanco has the ability to address our customers’ and society’s greatest needs. We look forward to partnering with, and learning from, our customers and stakeholders who share our drive to achieve these goals.”